Evidence map›Paper›PMID 35407606›Full record

ArticleJournal of clinical medicine2022

T

Ernst S Kooreman, Max Tanaka, Leon C Ter Beek, Femke P Peters, Corrie A M Marijnen, Uulke A van der Heide, Petra J van Houdt

Open access · goldAbstract read
In one paragraph

Article in Journal of clinical medicine, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 17 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 1 institution in 1 country.

Ernst S KooremanDepartment of Radiation Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Max TanakaDepartment of Radiation Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Leon C Ter BeekDepartment of Radiology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0002-5635-3169
Femke P PetersDepartment of Radiation Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Corrie A M MarijnenDepartment of Radiation Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Uulke A van der HeideDepartment of Radiation Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.
Petra J van HoudtDepartment of Radiation Oncology, The Netherlands Cancer Institute, 1066 CX Amsterdam, The Netherlands.ORCID 0000-0001-7431-8386
The Netherlands Cancer Institute · NL

Funding

ITEA3 16016 STARLIT
6 · The paper itself

Abstract

Quantitative MRI has the potential to produce imaging biomarkers for the prediction of early response to radiotherapy treatment. In this pilot study, a potential imaging biomarker, the T

Indexed as

MR-linacquantitative MRIT1rhotreatment response monitoring

Identifiers

PMID35407606
PMCPMC8999631
OpenAlexW4223617344

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.